Identification of 4 immune cells and a 5-lncRNA risk signature with prognosis for early-stage lung adenocarcinoma
Abstract Background Lung cancer is the most common cancer and cause of cancer‐related mortality worldwide, increasing evidence indicated that there was a significant correlation between tumors and the long non‐coding RNAs (lncRNAs), as well as tumor immune infiltration, but their role in early lung...
Main Authors: | Lan Mu, Ke Ding, Ranran Tu, Wei Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-021-02800-x |
Similar Items
-
Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
by: Guomin Wu, et al.
Published: (2021-07-01) -
Identification and Validation of a Novel Immune-Related Four-lncRNA Signature for Lung Adenocarcinoma
by: Jixin Wang, et al.
Published: (2021-02-01) -
Characterization of a ferroptosis and iron-metabolism related lncRNA signature in lung adenocarcinoma
by: Jie Yao, et al.
Published: (2021-07-01) -
Unique metastasis‐associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma
by: Xiaoshi Zhang, et al.
Published: (2020-03-01) -
Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature
by: Qi X, et al.
Published: (2021-08-01)